Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"Disease" Definition Is Key Issue In Structure/Function Claims Rule - Henney

This article was originally published in The Tan Sheet

Executive Summary

The appropriateness of the new definition of "disease" included in FDA's April 1998 proposed rule on structure/function claims is a key issue emerging from the more than 100,000 comments received on the proposal, FDA Commissioner Jane Henney, MD, noted at a House Government Reform Committee hearing March 25. The hearing was called to review FDA's implementation of the Dietary Supplement Health & Education Act, and, in particular, the structure/function claims proposal.

You may also be interested in...



Disclaimers May Be "Subterfuge" For Disease Claims, PhRMA Exec Warns

FDA should be cautious in allowing a disclaimer statement that could mislead consumers into believing dietary supplements can cure or prevent disease, a PhRMA rep maintained at FDA's Aug. 4 public meeting on the regulation of supplement structure/ function claims in Washington, D.C.

Disclaimers May Be "Subterfuge" For Disease Claims, PhRMA Exec Warns

FDA should be cautious in allowing a disclaimer statement that could mislead consumers into believing dietary supplements can cure or prevent disease, a PhRMA rep maintained at FDA's Aug. 4 public meeting on the regulation of supplement structure/ function claims in Washington, D.C.

Disclaimers May Be "Subterfuge" For Disease Claims, PhRMA Exec Warns

FDA should be cautious in allowing a disclaimer statement that could mislead consumers into believing dietary supplements can cure or prevent disease, a PhRMA rep maintained at FDA's Aug. 4 public meeting on the regulation of supplement structure/ function claims in Washington, D.C.

Related Content

Topics

UsernamePublicRestriction

Register

PS089591

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel